Creaney J - Search Results

1

Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related protein.

Creaney J, Robinson BW. Creaney J, et al. Hematol Oncol Clin North Am. 2005 Dec;19(6):1025-40, v. doi: 10.1016/j.hoc.2005.09.007. Hematol Oncol Clin North Am. 2005. PMID: 16325121 Review.

2

Neo-antigen specific T cell responses indicate the presence of metastases before imaging.

Fear VS, Forbes CA, Chee J, Ma S, Neeve S, Celliers L, Fisher SA, Dick I, Creaney J, Robinson BWS. Fear VS, et al. Among authors: creaney j. Sci Rep. 2019 Oct 10;9(1):14640. doi: 10.1038/s41598-019-51317-3. Sci Rep. 2019. PMID: 31601975 Free PMC article.

3

Mesothelin-family proteins and diagnosis of mesothelioma.

Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, Winzell P, Hellstrom KE, Hellstrom I. Robinson BW, et al. Among authors: creaney j. Lancet. 2003 Nov 15;362(9396):1612-6. doi: 10.1016/S0140-6736(03)14794-0. Lancet. 2003. PMID: 14630441

4

Soluble mesothelin-related protein--a blood test for mesothelioma.

Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, Winzell P, Hellstrom KE, Hellstrom I. Robinson BW, et al. Among authors: creaney j. Lung Cancer. 2005 Jul;49 Suppl 1:S109-11. doi: 10.1016/j.lungcan.2005.03.020. Lung Cancer. 2005. PMID: 15950789

5

Recombinant GM-CSF plus autologous tumor cells as a vaccine for patients with mesothelioma.

Powell A, Creaney J, Broomfield S, Van Bruggen I, Robinson B. Powell A, et al. Among authors: creaney j. Lung Cancer. 2006 May;52(2):189-97. doi: 10.1016/j.lungcan.2006.01.007. Epub 2006 Mar 24. Lung Cancer. 2006. PMID: 16563560 Clinical Trial.

6

Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma.

Creaney J, Yeoman D, Naumoff LK, Hof M, Segal A, Musk AW, De Klerk N, Horick N, Skates SJ, Robinson BW. Creaney J, et al. Thorax. 2007 Jul;62(7):569-76. doi: 10.1136/thx.2006.068114. Epub 2007 Mar 13. Thorax. 2007. PMID: 17356060 Free PMC article.

7

Soluble mesothelin related protein in mesothelioma.

Creaney J, Christansen H, Lake R, Musk AB, de Klerk N, Robinson BW. Creaney J, et al. J Thorac Oncol. 2006 Feb;1(2):172-4. J Thorac Oncol. 2006. PMID: 17409849 No abstract available.

8

Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma.

Creaney J, van Bruggen I, Hof M, Segal A, Musk AW, de Klerk N, Horick N, Skates SJ, Robinson BW. Creaney J, et al. Chest. 2007 Oct;132(4):1239-46. doi: 10.1378/chest.07-0013. Epub 2007 Jul 23. Chest. 2007. PMID: 17646232

9

Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study.

Roe OD, Creaney J, Lundgren S, Larsson E, Sandeck H, Boffetta P, Nilsen TI, Robinson B, Kjaerheim K. Roe OD, et al. Among authors: creaney j. Lung Cancer. 2008 Aug;61(2):235-43. doi: 10.1016/j.lungcan.2007.12.025. Epub 2008 Feb 20. Lung Cancer. 2008. PMID: 18281122

10

Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study.

Park EK, Sandrini A, Yates DH, Creaney J, Robinson BW, Thomas PS, Johnson AR. Park EK, et al. Among authors: creaney j. Am J Respir Crit Care Med. 2008 Oct 15;178(8):832-7. doi: 10.1164/rccm.200802-258OC. Epub 2008 Jun 26. Am J Respir Crit Care Med. 2008. PMID: 18583574

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results